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DEAR EDITOR 
Diabetes represents a major global public 
health threat and, together with obesity, 
constitutes an important contributor to a decline 
in life expectancy (1). The pathophysiology of 
type 2 diabetes is complex. In addition to 
impaired insulin secretion from pancreatic cells, a 
reduced insulin sensitivity is found to play a 
predominant role in the pathogenesis of the 
disease (2). Several circulating proteins are 
involved in the regulation of insulin sensitivity; 
such as, adiponectin, retinol binding protein 4, 
and fetuin-A (3). The fetuin family consists of a 
set of orthologous plasma proteins found in 
humans, sheep, pigs, cows and rodents. Fetuin-A 
has been identified as a major protein during fetal 
life and is also involved in important functions 
such as inhibition of insulin receptor tyrosine 
kinase activity, protease inhibitory activity and 
the development of associated regulation of 
calcium metabolism and osteogenesis. 
Furthermore, fetuin-A is a key component in the 
recovery phase of an acute inflammatory 
response. There is a second protein of the fetuin 
family, called fetuin-B, which is found at least in 
human and rodents. Fetuin-B was discovered in 
mice prone to diabetes.  Based on domain 
homology, overall conservation of cysteine 
residues and chromosomal assignments of the 
corresponding genes in these species, fetuin-B is 
a unambiguously paralogue of fetuin-A (3, 4). 
Recently, fetuin-B has also been identified as a 
novel adipokine/hepatokine which is significantly 
increased in hepatic steatosis and which mediates 
impaired insulin action, as well as glucose 
intolerance (4). Meex et al. demonstrated that 
secretion of fetuin-B by isolated hepatocytes is 
augmented in mice with hepatic steatosis as 
compared to control littermates and it impairs 
glucose homeostasis in both humans and rodents 
(4). Most interestingly, short hairpin RNA-
induced knockdown of plasma fetuin-B improved 
glucose tolerance in mice as compared to controls 
without any effect on body weight (4). Previous 
studies have shown that Fetuin-B is in high levels 
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in patients with Type 2 diabetes. In an 
experimental trial, patients were found to have 
high levels of Fetuin-B only if they were also pre-
diabetic or diabetic. Moreover, another study 
demonstrated that fetuin-B levels are increased in 
women with gestational diabetes mellitus 
compared with healthy pregnant control women 
(5).  Also Fetuin-B protein has been shown to 
impair the action of insulin in the body (5). This 
evidence collectively provides a clear and causal 
link between the development of non-alcoholic 
fatty liver disease (NAFLD) and the development 
of Type 2 diabetes. If we can develop a drug that 
can block this protein perhaps we may be able to 
prevent the development of diabetes in patients 
with NAFLD (5, 6).  
On the other hand, exercise training is well 
noted as one of the most effective behavioral 
factors in the prevention of diabetes and 
inflammation. Numerous studies have examined 
the effect of exercise training on diabetics, obese 
patients, and cardiovascular patients, confirming 
that exercise training is able to reduce insulin 
resistance, obesity, inflammatory markers and 
adipokines such as leptin, retinol binding protein 
4, resistin (associated with insulin resistance), 
while at the same time increasing adiponectin (7-
11).  The aforementioned points highlight the 
positive effect of exercise training on obesity, 
diabetes and inflammation risk factors (12); and, 
in turn, suggest the effect of exercise training on 
fetuin-B research is highly warranted – and as of 
yet remains unexamined. The study of fetuin-B 
and exercise may provide new insight and 
important understanding about the connections 
between, and prevention of diabetes, insulin 
resistance, and related diseases. We encourage 
exercise immunology and physiology researchers 
to examine the theoretical constructs present here 
and test the premise put forward.
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